Results for Fanconi Anemia

Dr. Kurre's laboratory has longstanding expertise in Fanconi Anemia (FA), a genetic condition with prominent hematologic complications. With training in transplantation and hematopoietic stem cell biology, he hopes to improve the understanding of the progressive hematopoietic failure in patients with bone marrow failure and FA, broaden diagnostic approaches, and develop next generation therapies.

Dr. Tong investigates cytokine receptor signaling in normal and neoplastic hematopoietic development. She uses integrated approaches encompassing biochemistry, molecular biology, mouse models, and primary human samples to understand signaling events emanating from cytokine receptors that regulate the development of hematopoietic stem/progenitor cells.

Linah Omer is a hematology-oncology fellow whose work is focused on understanding nanoparticle applications and their role in treatment of Fanconi anemia.

Omar Banda investigates therapeutic applications of novel nanoparticle delivery systems for the treatment of Fanconi Anemia.

Adams joined the Kurre Laboratory in 2022 and is working to understand clonal hematopoiesis in Fanconi Anemia to advance understanding of and treatments for pediatric hematological disorders.

Greer Jeffrey is a post-bac research technician in the Kurre Laboratory working to understand the fetal stem cell deficits in Fanconi Anemia.

Suying Liu leads the research project into the clonal restraints of hematopoiesis in an inherited bone marrow failure syndrome, Fanconi Anemia, to promote better understanding and treatment of pediatric hematological disorders.

Narasaiah Kovuru’s research focuses on understanding the origins of hematopoietic failure/bone marrow failure in Fanconi Anemia working with the murine model.